Wilke Michael, Hübner Claudia, Kämmerer Wolfgang
inspiring-health Dr. Wilke GmbH, Munich, Germany.
Lehrstuhl für Allgemeine Betriebswirtschaftslehre und Gesundheitsmanagement, Universität Greifswald, Germany.
GMS Infect Dis. 2020 Mar 26;8:Doc03. doi: 10.3205/id000047. eCollection 2020.
This is the seventeenth chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2 updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. This chapter analyses economic aspects of antiinfective therapy. Any treatment decision is also a cost decision. In this chapter the authors particularly analyse whether or not there is evidence that certain clinically effective strategies as Antimicrobial Stewardship programs (AMS), guideline adherent initial therapy, early diagnostics, De-escalation, sequence therapy or therapeutic drug monitoring also have benficial economic effects. These can be direct savings or shortening of length of stay to free resources.
这是《成人细菌性感染的初始肠外计算治疗指南 - 2018年更新》第二版中的第十七章。保罗·埃尔利希化疗协会（PEG）的德国指南已被翻译，以面向国际读者。本章分析抗感染治疗的经济方面。任何治疗决策同时也是一项成本决策。在本章中，作者特别分析了是否有证据表明某些临床有效的策略，如抗菌药物管理计划（AMS）、遵循指南的初始治疗、早期诊断下台阶治疗、序贯治疗或治疗药物监测，也具有有益的经济效果。这些效果可以是直接节省费用或缩短住院时间以释放资源。
